Please login to the form below

Not currently logged in
Email:
Password:

Palynziq

This page shows the latest Palynziq news and features for those working in and with pharma, biotech and healthcare.

BioMarin ticks over in Q2 ahead of gene therapy filing

BioMarin ticks over in Q2 ahead of gene therapy filing

our late stage clinical programmes, and higher marketing and sales expenses in support of the commercial launches of Palynziq and Brineura”. ... Analysts at William Blair say they will expect to see the impact of EU approval for Palynziq in Q3, which

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...